Cost effectiveness of trastuzumab in adjuvant treatment of early breast cancer: A model based analysis

被引：0
|
作者：
Dedes, Konstantin J.
Szucs, Thomas D.
Imesch, Patrick
Fehr, Mathias K.
Fink, Daniel
机构：
[1] Univ Zurich Hosp, Div Gynecol, CH-8091 Zurich, Switzerland
[2] Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [1] Cost effectiveness of trastuzumab in the adjuvant treatment of early breast cancer - A lifetime model
    Millar, J. Alasdair
    Millward, Michael J.
    PHARMACOECONOMICS, 2007, 25 (05) : 429 - 442
  • [2] Cost-effectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a model-based analysis of the HERA and FinHer trial
    Dedes, K. J.
    Szucs, T. D.
    Imesch, P.
    Fedier, A.
    Fehr, M. K.
    Fink, D.
    ANNALS OF ONCOLOGY, 2007, 18 (09) : 1493 - 1499
  • [3] Cost Effectiveness of Trastuzumab in the Adjuvant Treatment of Early Breast CancerA Lifetime Model
    J. Alasdair Millar
    Michael J. Millward
    PharmacoEconomics, 2007, 25 : 429 - 442
  • [4] Cost-effectiveness analysis of adjuvant therapy with trastuzumab for early breast cancer
    Wardley, Andrew M.
    Cameron, David A.
    Bell, Richard
    Erny, Samuel
    Cohen, Carole
    Geary, Una
    Walzer, Stefan
    Gyldmark, Marlene
    ANNALS OF ONCOLOGY, 2006, 17 : 95 - 96
  • [5] Trastuzumab in adjuvant breast cancer therapy: A model based cost-effectiveness analysis.
    Norum, J.
    Olsen, J. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 34S - 34S
  • [6] Trastuzumab in adjuvant breast cancer therapy. A model based cost-effectiveness analysis
    Norum, J.
    Olsen, J. A.
    Wist, E. A.
    Lonning, P. E.
    ACTA ONCOLOGICA, 2007, 46 (02) : 153 - 164
  • [7] The cost-effectiveness issue of adjuvant trastuzumab in early breast cancer
    Norum, Jan
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (12) : 1617 - 1625
  • [8] COST-EFFECTIVENESS OF ADJUVANT THERAPY WITH TRASTUZUMAB IN THE TREATMENT OF EARLY BREAST CANCER (EBC) IN ROMANIA
    Grecea, D.
    Baculea, S.
    Radu, P. C.
    Pana, B.
    Szkultecka-Debek, M.
    VALUE IN HEALTH, 2010, 13 (03) : A42 - A42
  • [9] COST-EFFECTIVENESS OF TRASTUZUMAB IN THE ADJUVANT TREATMENT OF EARLY BREAST CANCER IN SIX LATIN AMERICAN COUNTRIES
    Pichon-Riviere, A.
    Augustovski, F.
    Garay, O. U.
    Buendia, J.
    Rodriguez, A.
    Vallejos, C.
    Huayanay, L.
    Oliveira, C.
    VALUE IN HEALTH, 2011, 14 (07) : A538 - A538
  • [10] COST-EFFECTIVENESS OF ADJUVANT TRASTUZUMAB FOR EARLY BREAST CANCER IN ASIA: A SYSTEMATIC REVIEW
    Rafar, Abdul N. R.
    Neoh, C. F.
    Othman, M. F.
    Hong, Y. H.
    VALUE IN HEALTH, 2018, 21 : S14 - S14
12345